Publication | Closed Access

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Atopic DermatitisMedicineModerate-to-severe Atopic DermatitisSkin AllergyClinical DermatologyAd UpSkin PharmacologyPharmacotherapyDermatologyTopical CorticosteroidsSclerodermaDrug Allergy